Health and Healthcare

Vertex Pharmaceuticals : VRTX

All Vertex Pharmaceuticals Articles

252 Articles

Chris Lange | Mar 29, 2017 at 1:50 PM EDT

Why This Key Analyst Has a Mixed View of Vertex’s Win

Vertex Pharmaceuticals shares were jumping after the firm released results from two Phase 3 studies in the treatment of cystic…

Chris Lange | Mar 29, 2017 at 10:10 AM EDT

Tuesday’s Top Biopharma Movers

A few biopharma stocks made massive runs on Tuesday morning as the result of clinical trial results and earnings. Although…

Jon C. Ogg | Mar 29, 2017 at 9:05 AM EDT

Top Analyst Upgrades and Downgrades: Boeing, Capital One, CenturyLink, Morgan Stanley, NRG Energy, Vertex and Many More

The top analyst upgrades, downgrades and initiations seen on Wednesday include Boeing, Capital One, CenturyLink, Morgan Stanley, NRG Energy and…

Jon C. Ogg | Mar 17, 2017 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Adobe, Barclays, Dean Foods, Netflix, Simon Property, Snap, Vertex and More

The top analyst upgrades, downgrades and initiations seen on Friday include Adobe Systems, Barclays, Dean Foods, Netflix, Simon Property, Snap…

Jon C. Ogg | Mar 14, 2017 at 9:05 AM EDT

Top Analyst Upgrades and Downgrades: Mobileye, Occidental, Oracle, Disney, Wal-Mart and Many More

The top analyst upgrades, downgrades and initiations seen on Tuesday include Mobileye, Occidental Petroleum, Oracle, Walt Disney, Wal-Mart.

Chris Lange | Mar 6, 2017 at 1:45 PM EST

Monday’s Top Health Care Stocks Screaming Higher

Markets may be slowing down and taking a step back after hitting new highs in what has been known as…

Lee Jackson | Jan 19, 2017 at 8:40 AM EST

Baird Has 4 Red-Hot Biotechs to Buy for 2017 With Huge Upside Potential

A recent research report from the biotech team at Baird offers their top picks for 2017. While hardly pounding the…

Lee Jackson | Jan 10, 2017 at 8:35 AM EST

Jefferies Has 5 Top Biotech Stocks to Buy for 2017

Needless to say, the past two years have been rough on biotech. The question for investors is which of the…

Lee Jackson | Dec 22, 2016 at 8:25 AM EST

RBC Likes Large Cap Biotech Leaders for 2017

In a new research report, the biotech team at RBC reveal their top picks for 2017, and while hardly pounding…

Lee Jackson | Dec 15, 2016 at 8:55 AM EST

Top Analysts Upgrades and Downgrades: AMD, Comerica, General Mills, Mastercard, Vertex Pharmaceuticals and More

Thursday’s top analyst upgrades, downgrades and initiations include Advanced Micro Devices, Comerica, General Mills, Mastercard and Vertex Pharmaceuticals.

Lee Jackson | Dec 12, 2016 at 8:20 AM EST

4 Red-Hot Biotechs Highlight Jefferies Top Stocks to Buy

A series of new Jefferies reports focus on four biotech stocks that have big upside potential, regardless of the political…

Jon C. Ogg | Nov 29, 2016 at 9:05 AM EST

Top Analyst Upgrades and Downgrades: AK Steel, Celgene, Darden, Delphi Automotive, Johnson & Johnson, US Steel and More

The top analyst upgrades, downgrades and initiations seen on Tuesday morning include AK Steel, Celgene, Darden Restaurants, Delphi Automotive, Johnson…

Jon C. Ogg | Oct 24, 2016 at 9:05 AM EDT

Top Analyst Upgrades and Downgrades: Ariad Pharma, Comcast, ConEd, Electronic Arts, Kinder Morgan, 3M, Time Warner and More

The top analyst upgrades, downgrades and initiations seen on Monday morning include Ariad Pharmaceuticals, Comcast, ConEd, Electronic Arts, Kinder Morgan,…

Lee Jackson | Oct 6, 2016 at 9:50 AM EDT

Big Pharma and Top Biotechs Highlight Jefferies Stocks to Buy Now

In a new research report from Jefferies, many of the outstanding companies in pharmaceuticals and biotech space show up among…

Chris Lange | Sep 14, 2016 at 8:20 AM EDT

Key FDA Decisions and Trial Results Coming in the Next 2 Months

24/7 Wall St. has collected several big FDA decisions and mid- to late-stage trials that should be coming up in…

1 … 6 7 8 9 10 … 17

Vertex Pharmaceuticals : VRTX

All Vertex Pharmaceuticals Articles

Why This Key Analyst Has a Mixed View of Vertex’s Win

Tuesday’s Top Biopharma Movers

Top Analyst Upgrades and Downgrades: Boeing, Capital One, CenturyLink, Morgan Stanley, NRG Energy, Vertex and Many More

Top Analyst Upgrades and Downgrades: Adobe, Barclays, Dean Foods, Netflix, Simon Property, Snap, Vertex and More

Top Analyst Upgrades and Downgrades: Mobileye, Occidental, Oracle, Disney, Wal-Mart and Many More

Monday’s Top Health Care Stocks Screaming Higher

Baird Has 4 Red-Hot Biotechs to Buy for 2017 With Huge Upside Potential

Jefferies Has 5 Top Biotech Stocks to Buy for 2017

RBC Likes Large Cap Biotech Leaders for 2017

Top Analysts Upgrades and Downgrades: AMD, Comerica, General Mills, Mastercard, Vertex Pharmaceuticals and More

4 Red-Hot Biotechs Highlight Jefferies Top Stocks to Buy

Top Analyst Upgrades and Downgrades: AK Steel, Celgene, Darden, Delphi Automotive, Johnson & Johnson, US Steel and More

Top Analyst Upgrades and Downgrades: Ariad Pharma, Comcast, ConEd, Electronic Arts, Kinder Morgan, 3M, Time Warner and More

Big Pharma and Top Biotechs Highlight Jefferies Stocks to Buy Now

Key FDA Decisions and Trial Results Coming in the Next 2 Months

Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

3 Dividend Stocks Built for Retirement to Buy in June

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

A $900,000 Nest Egg at 65 Only Translates to About $36,000 in Real Annual Spending After Taxes and Inflation

Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

Vertex Pharmaceuticals : VRTX

All Vertex Pharmaceuticals Articles

Why This Key Analyst Has a Mixed View of Vertex’s Win

Tuesday’s Top Biopharma Movers

Top Analyst Upgrades and Downgrades: Boeing, Capital One, CenturyLink, Morgan Stanley, NRG Energy, Vertex and Many More

Top Analyst Upgrades and Downgrades: Adobe, Barclays, Dean Foods, Netflix, Simon Property, Snap, Vertex and More

Top Analyst Upgrades and Downgrades: Mobileye, Occidental, Oracle, Disney, Wal-Mart and Many More

Monday’s Top Health Care Stocks Screaming Higher

Baird Has 4 Red-Hot Biotechs to Buy for 2017 With Huge Upside Potential

Jefferies Has 5 Top Biotech Stocks to Buy for 2017

RBC Likes Large Cap Biotech Leaders for 2017

Top Analysts Upgrades and Downgrades: AMD, Comerica, General Mills, Mastercard, Vertex Pharmaceuticals and More

4 Red-Hot Biotechs Highlight Jefferies Top Stocks to Buy

Top Analyst Upgrades and Downgrades: AK Steel, Celgene, Darden, Delphi Automotive, Johnson & Johnson, US Steel and More

Top Analyst Upgrades and Downgrades: Ariad Pharma, Comcast, ConEd, Electronic Arts, Kinder Morgan, 3M, Time Warner and More

Big Pharma and Top Biotechs Highlight Jefferies Stocks to Buy Now

Key FDA Decisions and Trial Results Coming in the Next 2 Months

Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

3 Dividend Stocks Built for Retirement to Buy in June

Featured Reads

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

A $900,000 Nest Egg at 65 Only Translates to About $36,000 in Real Annual Spending After Taxes and Inflation